Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 478

Results For "Mark"

5325 News Found

Cadila Pharma launches ayurvedic energy tonic Healtherbs
Healthcare | December 08, 2021

Cadila Pharma launches ayurvedic energy tonic Healtherbs

Healtherbs helps in restoring the desired energy levels for daily activity and immunity


IPM registers 6 % yoy revenue growth in Nov 2021.
News | December 08, 2021

IPM registers 6 % yoy revenue growth in Nov 2021.

Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.


RDIF offers vaccine for adolescents aged 12-17 in India
News | December 07, 2021

RDIF offers vaccine for adolescents aged 12-17 in India

Sputnik M is a new member of the Sputnik vaccines family


Biocon partners with Tabuk Pharmaceuticals as it expands in the Middle East
News | December 07, 2021

Biocon partners with Tabuk Pharmaceuticals as it expands in the Middle East

As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them


Fujifilm collaborates with DCC Animal hospital for diagnostics support
Clinical Trials | December 07, 2021

Fujifilm collaborates with DCC Animal hospital for diagnostics support

Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.


Wipro-GE unveils B2B e-commerce platform for medical equipment
Medical Device | December 07, 2021

Wipro-GE unveils B2B e-commerce platform for medical equipment

It is an extension of GE Healthcare’s online service delivery enterprise Service Shop


AWS partners with Pfizer to accelerate drug development
Biotech | December 06, 2021

AWS partners with Pfizer to accelerate drug development

It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies


Lupin and Biomm  tie-up for pegfilgrastim in Brazil
News | December 05, 2021

Lupin and Biomm tie-up for pegfilgrastim in Brazil

Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever


Eris signs JV with MJ Biopharm to supply insulin in India
News | December 05, 2021

Eris signs JV with MJ Biopharm to supply insulin in India

MJ will be paid a one-time lumpsum licence fee of Rs 15 crore